Hsien-Tsung LU

Full Name
Hsien-Tsung LU
Nationality
Taiwan
Position
Director of Orthopaedic Sport Medicine
Organization
Taipei Medical University Hospital
Brief Bio
As an orthopedic surgeon, my daily practice revolves around the intricate realm of bone and cartilage repair, with a primary focus on treating orthopedic conditions like arthritis and osteoporosis. My clinical approach integrates state-of-the-art technologies such as 3D printing, computer navigation, and ultrasound to rectify bone deformities, encompassing the correction of complex fractures, artificial joint replacement, and ligament reconstruction in sports medicine. In the sphere of research, my endeavors span cell therapy and various bioengineering innovations. These pursuits aim to unravel the depths of orthopedic conditions, promising novel solutions. I am eager to share insights and engage in discourse on these compelling subjects.
Specialty
-Sport medicine ; osteoporosis -Knee and hip joint replacement
Education
-Taipei Medical University, Taipei, Taiwan. Doctor of Philosophy, Graduate Institute of Clinical Medicine -Harvard School of Public Health, Boston, U.S.A. Master of Public Health -Taipei Medical University, Bachelor of Medicine
Honors/Awards
-2020 The 17th National Innovation Award, Clinical research Category, Distal radius fracture minimally invasive 3D printing reduction instrument -2020 16th International Salon of Inventions and New Technologies Gold Medal Award-Wrist arthroscopic Assistive Device. Sevastopol, Russian Federation September, 24-26 2020 -2018 International Warsaw Invention Show IWIS 2018 Gold Medal Award-Ligament reconstruction assistive device, 15-17 October 2018 Warsaw
Publication
-Modification of chitosan nanofibers with CuS and fucoidan for antibacterial and bone tissue engineering applications; Carohydrate polymer 2022 Jan; 281(36):119035 -A smart and active film with tunable drug release and color change abilities for detection and inhibition of bacterial growth; Materials Science and Engineering: C Volume 118, January 2021, 111396 -A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan/hyaluronic acid polymer blending for sustained release of berberine. Carbohydrate Polymers.(206):664-673. -Development of nanocomposite scaffolds based on biomineralization of N,O-carboxymethyl chitosan/fucoidan conjugates for bone tissue engineering; International Journal of Biological Macromolecules 120 (2018) 2335–2345.